News

New product

Early access product launch for ioSensory Neurons

bit.bio launches early access to ioSensory Neurons for chronic pain research and therapeutics development for peripheral neuropathies.

18.05.2023

Published by bit.bio

bit.bio launches early access to ioSensory Neurons for chronic pain research and therapeutics development for peripheral neuropathies.

Published by bit.bio

Read now

New product

Three new products for neurological and neurodegenerative disease

Further products in CNS portfolio aim to address the translation gap and accelerate research and drug discovery for neurodegenerat...

23.11.2022

Published by bit.bio

Read now

New product

New cell products for neurodegenerative disease

Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.

29.09.2022

Published by bit.bio

Read now

New product

bit.bio launches Huntington’s disease human cell model

The new Huntington’s disease human cell model is built with opti-ox reprogrammed glutamatergic neurons.

08.05.2022

Published by bit.bio

Read now

New product

New product launch | ioSkeletal Myocytes

This is the first supply of consistent, scalable, human muscle cells, providing transformative new models for drug discovery.

14.10.2021

Published by bit.bio

Read now

Related pages